VEGF Receptor 1-Expressing Macrophages Recruited from Bone Marrow Enhances Angiogenesis in Endometrial Tissues
暂无分享,去创建一个
M. Shibuya | Tomoyoshi Inoue | N. Unno | M. Majima | Yoshiya Ito | K. Hosono | H. Amano | A. Numao | K. Hattori | Masako Honda | Kazuki Sekiguchi
[1] S. Akira,et al. Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice. , 2018, Journal of hepatology.
[2] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[3] Hongbo Wang,et al. Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis , 2016, PloS one.
[4] Takao Shimizu,et al. BLT1 signalling protects the liver against acetaminophen hepatotoxicity by preventing excessive accumulation of hepatic neutrophils , 2016, Scientific Reports.
[5] M. Shibuya,et al. Vascular endothelial growth factor regulates growth of endometrial tissues and angiogenesis in a mouse transplantation model , 2016 .
[6] M. Shibuya,et al. The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia , 2015, PloS one.
[7] Ramazan Mammadov,et al. Cyclamen graecum ekstraktlarının sıçan alt gastrointestinal sistem üzerindeki etkilerinin histokimyasal olarak araştırılması , 2015 .
[8] M. Shibuya,et al. VEGFR1-Positive Macrophages Facilitate Liver Repair and Sinusoidal Reconstruction after Hepatic Ischemia/Reperfusion Injury , 2014, PloS one.
[9] M. Shibuya,et al. Vascular endothelial growth factor receptor 1 signaling facilitates gastric ulcer healing and angiogenesis through the upregulation of epidermal growth factor expression on VEGFR1+CXCR4+ cells recruited from bone marrow , 2014, Journal of Gastroenterology.
[10] Seungwon Kim,et al. A Proangiogenic Signature Is Revealed in FGF-Mediated Bevacizumab-Resistant Head and Neck Squamous Cell Carcinoma , 2013, Molecular Cancer Research.
[11] M. Shibuya,et al. VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy , 2013, EMBO molecular medicine.
[12] I. Fraser,et al. Angiogenesis, lymphangiogenesis and neurogenesis in endometriosis. , 2013, Frontiers in bioscience.
[13] M. Shibuya,et al. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. , 2013, Journal of biochemistry.
[14] Stephen H Kennedy,et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. , 2011, Fertility and sterility.
[15] K. Alitalo,et al. Roles of Prostaglandin E2–EP3/EP4 Receptor Signaling in the Enhancement of Lymphangiogenesis During Fibroblast Growth Factor-2–Induced Granulation Formation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[16] C. Lewis,et al. Cancer: Macrophages limit chemotherapy , 2011, Nature.
[17] S. Akira,et al. The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[18] L. Giudice. Clinical practice. Endometriosis. , 2010, The New England journal of medicine.
[19] S. Narumiya,et al. Tumorigenesis and Neoplastic Progression COX-2 and Prostaglandin EP 3 / EP 4 Signaling Regulate the Tumor Stromal Proangiogenic Microenvironment via CXCL 12-CXCR 4 Chemokine Systems , 2010 .
[20] Kjetil Boye,et al. S100A4 and metastasis: a small actor playing many roles. , 2010, The American journal of pathology.
[21] Eric O. Aboagye,et al. The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo. , 2009, Cancer research.
[22] A. Fukamizu,et al. Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] R. Schwendener,et al. Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. , 2009, The American journal of pathology.
[24] S. Narumiya,et al. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth. , 2009, Biochemical and biophysical research communications.
[25] Kenji Sunagawa,et al. Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase–Deficient Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[26] J. Pollard. Trophic macrophages in development and disease , 2009, Nature Reviews Immunology.
[27] Robert N. Taylor,et al. Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis , 2009, Reproductive sciences.
[28] C. Becker,et al. Endometriosis and angiogenesis. , 2008, Minerva ginecologica.
[29] M. Shibuya. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. , 2008, BMB reports.
[30] J. Palmblad,et al. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. , 2007, Human reproduction.
[31] M. Menger,et al. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. , 2007, Human reproduction update.
[32] K. Alitalo,et al. Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.
[33] Tae Funakoshi,et al. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. , 2006, The American journal of pathology.
[34] Fan Zhang,et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes , 2006, Nature Medicine.
[35] Napoleone Ferrara,et al. Angiogenesis as a therapeutic target , 2005, Nature.
[36] A. Nap,et al. Vascular development in endometriosis , 2005, Angiogenesis.
[37] Y. Taketani,et al. Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein. , 2005, Human reproduction.
[38] Napoleone Ferrara,et al. Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.
[39] Makoto Murakami,et al. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. , 2004, Progress in lipid research.
[40] H. Matsubara,et al. Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells , 2003, Circulation research.
[41] M. Majima,et al. COX-2/VEGF-Dependent Facilitation of Tumor-Associated Angiogenesis and Tumor Growth in vivo , 2003, Laboratory Investigation.
[42] R. Vile,et al. Autologous Culture-Modified Mononuclear Cells Confer Vascular Protection After Arterial Injury , 2003, Circulation.
[43] K. Osteen,et al. Antiangiogenic Agents Are Effective Inhibitors of Endometriosis , 2003 .
[44] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[45] Yukihiko Sugimoto,et al. Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth , 2003, The Journal of experimental medicine.
[46] Yukihiko Sugimoto,et al. Host Prostaglandin E 2-EP 3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth , 2003 .
[47] M. Itoman,et al. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. , 2002, Biochemical and biophysical research communications.
[48] S. Yamashina,et al. Adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in vivo. , 2001, Japanese journal of pharmacology.
[49] S. Yamashina,et al. Cyclo‐oxygenase‐2 enhances basic fibroblast growth factor‐induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants , 2000, British journal of pharmacology.
[50] J. Mclaren. Vascular endothelial growth factor and endometriotic angiogenesis. , 2000, Human reproduction update.
[51] T. Noda,et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] B. Eskenazi,et al. Epidemiology of endometriosis. , 1997, Obstetrics and gynecology clinics of North America.
[53] M. Vignali,et al. Basic fibroblast growth factor messenger ribonucleic acid levels in eutopic and ectopic human endometrial stromal cells as assessed by competitive polymerase chain reaction amplification , 1995, Molecular and Cellular Endocrinology.
[54] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[55] M. Nisolle,et al. Morphometric study of the stromal vascularization in peritoneal endometriosis. , 1993, Fertility and sterility.
[56] D. Charnock-Jones,et al. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. , 1993, Human reproduction.